Prairie Village, KS, United States of America

Meindert Niemeijer

This inventor holds 13 USPTO granted patents and 6 published patent applications and 2 EPO patents. Top assignees: Digital Diagnostics Inc., University of Iowa Research Foundation, The United States Government as Represented by the Department of Veterans Affairs. Active years: 2009-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Meindert Niemeijer. Retrieved from https://idiyas.com/inventor/meindert-niemeijer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 6)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 3)

Average Co-Inventor Count = 5.0

ph-index = 3

Forward Citations = 99(Granted Patents)

Location History:

Utrecht, NL (2009 - 2012)
Prairie Village, KS (US) (2018 - 2023)
Iowa City, IA (US) (2023 - 2024)
Coralville, IA (US) (2024)

Company Filing History:

7 out of 23

Digital Diagnostics Inc.

patents

5 out of 925

University of Iowa Research Foundation

patents

3 out of 957

The United States Government as Represented by the Department of Veterans Affairs

where one patent can have more than one assignee

Years Active: 2009-2025

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12369793 - Automated determination of arteriovenous ratio in images of blood vessels (2025-07-29),

2. 12322106 - Image retention and stitching for minimal-flash eye disease diagnosis (2025-06-03),

3. 12243206 - System and methods for qualifying medical images (2025-03-04),

4. 12171496 - Using infrared to detect proper eye alignment before capturing retinal images (2024-12-24),

5. 12035971 - Automated determination of arteriovenous ratio in images of blood vessels (2024-07-16),

6. 11980420 - Dynamic adjustment of flash intensity based on retinal pigmentation (2024-05-14),

7. 11880976 - Image retention and stitching for minimal-flash eye disease diagnosis (2024-01-23),

8. 11790523 - Autonomous diagnosis of a disorder in a patient from image analysis (2023-10-17),

9. 11638522 - Automated determination of arteriovenous ratio in images of blood vessels (2023-05-02),

10. 11232548 - System and methods for qualifying medical images (2022-01-25),

11. 10115194 - Systems and methods for feature detection in retinal images (2018-10-30),

12. 8194936 - Optimal registration of multiple deformed images using a physical model of the imaging distortion (2012-06-05),

13. 7474775 - Automatic detection of red lesions in digital color fundus photographs (2009-01-06),

Title: Meindert Niemeijer - Innovator in Medical Imaging Technology

Introduction

Meindert Niemeijer is a prominent inventor based in Prairie Village, Kansas, known for his significant contributions to medical imaging technology. With a total of 13 patents to his name, he has developed innovative methods that enhance the diagnosis and understanding of various medical conditions.

Latest Patents

One of his latest patents is focused on the automated determination of the arteriovenous ratio in images of blood vessels. This method can automatically determine the Arteriolar-to-Venular diameter Ratio (AVR) in blood vessels, which is a crucial predictor of risks associated with stroke, cognitive decline, and myocardial infarction. Another notable patent involves image retention and stitching for minimal-flash eye disease diagnosis. This system minimizes retinal exposure to flash during image gathering, ensuring accurate diagnosis while protecting patient safety.

Career Highlights

Throughout his career, Meindert has worked with notable organizations such as Digital Diagnostics Inc. and the University of Iowa Research Foundation. His work has significantly advanced the field of medical imaging, particularly in the diagnosis of retinal diseases.

Collaborations

Meindert has collaborated with esteemed colleagues, including Michael D. Abramoff and Warren Clarida. These partnerships have fostered innovation and contributed to the development of cutting-edge medical technologies.

Conclusion

Meindert Niemeijer continues to

Profile summary based on public USPTO records.